Is biologic therapy effective for my psoriatic arthritis?

Question

Hello doctor,

I am a 38-year-old man who has been dealing with psoriasis for nearly 10 years and was recently diagnosed with psoriatic arthritis. Over the past year, I have experienced pain, stiffness, and swelling in my fingers, knees, and lower back, especially in the morning.

My ESR is 42 mm/h, and my CRP is 18 mm/l, indicating inflammation. X-rays of my hands show joint space narrowing and early erosions. My rheumatoid factor (RF) and anti-CCP antibodies are negative.

I am currently using topical Calcipotriol for skin lesions and taking Methotrexate 20 milligrams weekly, but the joint pain continues to interfere with my daily activities. I have also noticed nail pitting and occasional heel pain.

My body mass index (BMI) is 30, and my liver enzymes are slightly elevated, possibly due to Methotrexate. My doctor mentioned starting a biologic medication such as Adalimumab if symptoms persist. I am concerned about its safety, risk of infection, and cost.

What are the best ways to control inflammation, protect my joints, and manage psoriasis together while minimizing medication side effects?

Kindly advise.

Answer 1

Hello,

Welcome to icliniq.com.

I understand the concern.

You are dealing with findings that are consistent with active psoriatic arthritis, with elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), early erosions on X-ray, nail pitting, heel pain (enthesitis), and persistent joint symptoms despite Methotrexate therapy. Once erosions are present, the priority becomes tight control of inflammation to prevent permanent joint damage.

If Methotrexate at 20 milligrams weekly is not adequately controlling the disease and liver enzyme levels are rising, escalation to a biologic agent such as Adalimumab is a standard and evidence-based next step.

Tumor necrosis factor (TNF) inhibitors target key inflammatory pathways that drive both joint and skin disease. These medications have been shown to reduce swelling and stiffness, slow radiographic progression, improve nail and skin psoriasis, and often reduce fatigue.

While biologic agents slightly increase the risk of infection, serious infections are uncommon with appropriate screening and monitoring. This includes testing for tuberculosis, hepatitis B, and hepatitis C before initiating therapy.

Mildly elevated liver enzyme levels may be related to Methotrexate use and a body mass index (BMI) of 30, as nonalcoholic fatty liver disease can coexist. Modest weight loss, even five to ten percent of body weight, can significantly improve inflammation and liver health.

Comprehensive management includes optimizing medication, engaging in regular low-impact exercise, avoiding smoking, moderating alcohol intake, and ensuring adequate vitamin D levels.

At 38 years of age, the goal is long-term joint preservation and sustained disease control. Transitioning to a biologic agent is not a failure of treatment, but rather a proactive strategy to prevent disease progression and maintain physical function.

I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.

Thank you.